IPP Bureau
AIkido Pharma improves manufacturing process for pancreatic drug
By IPP Bureau - March 04, 2022
The company also reported the issuance of an additional U.S. patent covering the drug, and the filing of a continuation patent application intended to expand patent coverage to other facets of the drug
Oragenics announces positive data on Covid-19 intranasal vaccine
By IPP Bureau - March 04, 2022
Intranasal immunization lowers the viral load below the limit of detection in lungs of hamsters
USFDA issues final guidance on voluntary recalls
By IPP Bureau - March 04, 2022
The guidance also urges companies to act quickly to initiate a recall when public health is at risk and to do so prior to completing an investigation into the cause of the problem
WuXi STA passes EMA drug product pre-approval inspection at its Wuxi City site
By IPP Bureau - March 04, 2022
WuXi STA’s drug product site in Wuxi City offers a full range of services including formulation development and manufacturing for a broad range of oral and injectable dosage forms
WHO and MPP welcome NIH’s offer of COVID-19 health technologies to C-TAP
By IPP Bureau - March 04, 2022
Launched in 2020, C-TAP aims to facilitate timely, equitable and affordable access to Covid-19 health products by boosting their production and supply through open, non-exclusive licensing agreements
AbbVie acquires Syndesi Therapeutics, strengthening neuroscience portfolio
By IPP Bureau - March 04, 2022
Expands AbbVie's neuroscience portfolio, adding first-in-class modulators of the synaptic vesicle protein 2A, including lead molecule SDI-118 currently in Phase 1b studies
New CellScape system for high-plex and high-throughput targeted spatial proteomics
By IPP Bureau - March 04, 2022
ChipCytometry delivers single-cell targeted spatial proteomics for complex whole-tissue analysis of the tumour microenvironment, as well as deep immune profiling for applications in immunology, neuroscience, and infectious disease
Known Medicine partners with Duke University to predict lung cancer response to drug treatments
By IPP Bureau - March 04, 2022
Collaboration aims to capture patient-to-patient variability to determine the best treatment for every cancer
Scientific leaders signal major breakthroughs in elimination of cervical and anal cancers
By IPP Bureau - March 04, 2022
To mark International HPV Awareness Day on March 4th 2022, the International Papillomavirus Society (IPVS) has warmly welcomed two major advances in the elimination of cervical and anal cancers
MFine launches heart rate monitoring tool on its App
By IPP Bureau - March 04, 2022
It plans launch various other health monitoring tools for smartphones, making existing devices obsolete
Aster Labs expands across south and west India
By IPP Bureau - March 04, 2022
A total of 17 labs will be operational across the country by this month
USFDA refuses to grant EUA to Covaxin for padeatric use
By IPP Bureau - March 04, 2022
Covaxin is not approved in the USA for any age group
MIBCON NDC offers CO2 Optimisation module
By IPP Bureau - March 04, 2022
The CO2 Optimization module is one of the four modules (Product Costing, BoM Management, CO2 Optimization, Supplier Strategy) within the entire NDC Simulation Suite
Govt announces over Rs 100 crore investment for Ayush sector in Nagaland
By IPP Bureau - March 04, 2022
Ten new Ayush hospitals and one Ayurvedic college will be set up in Nagaland and Mizoram
Alkem licenses technology from Harvard to treat ischemic injury and vascular diseases
By IPP Bureau - March 03, 2022
Novel delivery of established growth and neurotrophic factors enables local, sustained release for greater efficacy
